How many drugs treat Compensated cirrhosis?

Drug Landscape tracks 3 marketed treatments for Compensated cirrhosis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/compensated-cirrhosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Compensated cirrhosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compensated cirrhosis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Compensated cirrhosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Mavyret	GLECAPREVIR	AbbVie	Hepatitis C Virus NS5A Inhibitor [EPC]		2017-01-01
Sovaldi	Sovaldi	Genuine Research Center, Egypt		Cereblon isoform 4, Genome polyprotein, NS5
Ribavarin	Ribavarin	Charles University, Czech Republic		Cytosolic purine 5'-nucleotidase, Adenosine kinase, Ectonucleotide pyrophosphatase/phosphodiesterase family member 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 1 drug in Compensated cirrhosis
Charles University, Czech Republic · 1 drug in Compensated cirrhosis
Genuine Research Center, Egypt · 1 drug in Compensated cirrhosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Compensated cirrhosis:

Cite this brief

Drug Landscape (2026). Compensated cirrhosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/compensated-cirrhosis. Accessed 2026-06-10.

Compensated cirrhosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing